Burns & Levinson announced today that three highly accomplished life sciences attorneys – Daniel W. Clarke, Ph.D., Christopher R. Cowles, Ph.D., and Richard B. Emmons, Ph.D. – have joined the firm as partners in its Life Sciences and Intellectual Property Groups. Together, the team brings over three decades of combined experience representing innovative clients in the life sciences and technology sectors on intellectual property matters. Their expertise expands the depth and breadth of the intellectual property practice at Burns & Levinson and allows Drs. Clarke, Cowles, and Emmons to provide clients with seasoned advice and unparalleled service. They were previously with Mintz Levin in Boston.
“Our life sciences and intellectual property practices continue to grow in response to increasing demand for the client-focused and results-oriented legal services that our firm provides,” said David P. Rosenblatt, managing partner at Burns & Levinson. “We are committed to strategically growing our Intellectual Property Group into one of the nation’s top IP practices, and are always looking to add exceptional talent to our world-class team. Dan, Chris, and Richard are impressive attorneys who will be a great asset to our high profile life sciences clients.”
Dr. Clarke counsels clients in strategic patent procurement, IP due diligence, and worldwide prosecution in the area of biotechnology and the life sciences. He works with a broad range of clients – from smallbiotech start-ups and academic institutions, to mid-sized and large biotechnology and pharmaceutical companies – in the fields of cellular and molecular biology, oncology, immunology, microbiology, and virology, among others. In 2016, he was recognized as a Rising Star by Massachusetts Super Lawyers and as a Future Leader by the Greater Boston Chamber of Commerce.
Dr. Cowles possesses law firm and in-house experience in biotechnology patent preparation and prosecution, domestic and international IP portfolio management, and IP due diligence. His areas of expertise includeoligonucleotide therapeutics, oncology, diagnostics, antibody, microbiology, virology, cell biology, and genomic technologies. He performed post-doctoral research at the Whitehead Institute/MIT as a Damon Runyon fellow, and has been recognized as a Rising Star in 2016 by Massachusetts Super Lawyers.
Dr. Emmons counsels corporate and institutional clients in the preparation and prosecution of U.S. and foreign patents in the life sciences, medical device, and mechanical art areas. He assists clients with IP due diligence, IP licensing, andpatentability, infringement, validity, and freedom-to-operate analyses. His areas of expertise include cell and molecular biology, genetics, and developmental biology. He also performed post-doctoral research in the Department of Genetics at the Harvard Medical School. He has been recognized as a Rising Star (2014-2016) by Massachusetts Super Lawyers.
The legal and scientific prowess of Drs. Clarke, Cowles, and Emmons further enhances Burns’ existing team of high-caliber IP and business attorneys who advise life sciences companies throughout their life cycle – from technology and product licensing, patent and trademark procurement and enforcement, and strategic partnering and acquisitions to public and private financings, cross-border transactions, and export regulation compliance. The firm represents life sciences companies and entrepreneurs around the globe in diverse industries including biotechnology, clinical diagnostics, health care, medical devices, medical equipment, and pharmaceuticals, as well as academic institutions and research organizations.